Our latest episode is about digital therapeutics and what we can expect in the future. It also cover a very interesting report from MHRA and NICE on digital health apps used in patients with mental health and feedback from users and specialists. #digitalhealth #trends #mentalhealth
SOLUTIONS OP LTD’s Post
More Relevant Posts
-
Our latest episode is out! You can learn about digital health trends and the chances to find funding in this area. It also covers MHRA and NICE report on digital health solutions in mental health. It is very interesting to hear what users think of digital health applications. #digitalhealth #mentalhealth
Our latest episode is about digital therapeutics and what we can expect in the future. It also cover a very interesting report from MHRA and NICE on digital health apps used in patients with mental health and feedback from users and specialists. #digitalhealth #trends #mentalhealth
Solutions OP Clinical Trials UK - Digital Therapeutics Trends And Expectations | RSS.com
rss.com
To view or add a comment, sign in
-
Salman Fazal, MD; Yvonne Efebera, MD; Sumit Madan, MD, Ruemu Birhiray, MD, discuss how evaluating real-world efficacy and safety outcomes of GPRC5D-targeted therapies, along with identifying practical challenges and considerations, can guide the implementation of bispecifics in community practices. https://lnkd.in/egNMkkY4
GPRC5D-Targeted Therapies in Relapsed Multiple Myeloma: Real-World Results and Community Practice Challenges
cancernetwork.com
To view or add a comment, sign in
-
Each area of advancement, from precision medicine to immunology to cell and gene therapy, faces unique access barriers. Join experts from MMIT and The Dedham Group for an in-depth webinar on how pharma companies can address these barriers: https://ow.ly/jv9050RIWJ9.
Overcoming the Barriers to Patient Access in 2024 and Beyond | Register for the Webinar
event.on24.com
To view or add a comment, sign in
-
Learn about the unmet needs in patients with mental health conditions that prescription digital therapeutics (PDTs) may be able to address from Arwen Podesta, MD, ABPN, FASAM, ABIHM. Discover how PDTs are used along with existing therapies in the mental health care space. Watch the K-Cast series to for more information:https://bit.ly/4fErc2l. #ManagedCare #MentalHealthCare #PDT
To view or add a comment, sign in
-
Immunocal and lung diseases have been a life-changing combination for Cathy, a real-life user sharing her story. Cathy, diagnosed with Interstitial Lung Disease, found hope through Immunocal, a natural health product with 40 years of clinical research backing at McGill University Medical Research Centre. This innovative product, known to raise critical molecules like glutathione, has significantly improved Cathy's breathing after years of struggle. Cathy initially took one pack of Immunocal daily for two years before increasing her intake to two packs per day, leading to noticeable improvements in her energy levels and breathlessness. Against the odds, Cathy now enters her 5th year on Immunocal, defying her fatal prognosis and proving the product's effectiveness. Her respirologist is astonished by her progress, emphasizing the remarkable impact of Immunocal and glutathione on her quality of life. Cathy's gratitude for this life-saving product shines through her testimony. Cathy's inspiring journey serves as a beacon of hope and resilience for individuals battling lung diseases. To learn more about Immunocal and its transformative benefits, visit www.immunotec.com/possom. #lunghealth #asthma #copdtreatment #immunesystemhealth #immunesupport #InterstitialLungDisease #Glutathione #GSH #breathingexercises #lungdiseaseawareness #immunocalregular
Immunotec | Home - Immunotec Inc.
immunotec.com
To view or add a comment, sign in
-
Each area of advancement, from precision medicine to immunology to cell and gene therapy, faces unique access barriers. Join experts from MMIT and The Dedham Group for an in-depth webinar on how pharma companies can address these barriers: https://ow.ly/vyIL50RIY80.
Overcoming the Barriers to Patient Access in 2024 and Beyond | Register for the Webinar
event.on24.com
To view or add a comment, sign in
-
The value of including time-based models in clinical outcomes reporting: practical, real-life meaning. https://lnkd.in/dehfrsPd
Researchers call for a major rethink of how Alzheimer’s treatments are evaluated
nature.com
To view or add a comment, sign in
-
Research and investment around #exosomes and their diverse roles in health and disease continues to grow, creating a complex and competitive #IP landscape. Read our executive summary to explore key trends and IP considerations for innovators in this area. https://ow.ly/ZmNz50QIMIM
Keeping a finger on the pulse of exosome IP and innovation
cas.org
To view or add a comment, sign in
-
This tool can improve your sickle cell disease clinical trial! The ASH DEI Toolkit for Clinical Trial Sponsors has recommendations, reference articles, & additional resources from both national and international regulatory bodies. While the toolkit doesn't focus on sickle cell disease specifically, it will help you: ✔️Consider DEI principles from the start ✔️Engage the patient community early & often ✔️Be thoughtful about exclusion criteria ✔️Leverage tools to meet the patients where they are ✔️Engage primary care doctors in the trial process Download it here: https://ow.ly/pQ2g50Tujhh #SickleCellAwarenessMonth #ClinicalResearch #SickleCell #SickleCellDisease #SCD #DEI #ClinicalTrials #ClinicalResearcher #ClinicalTrialDesign #RegulatoryCompliance #DiversityInClinicalTrials #MedicalResearch #RareDiseaseResearch
To view or add a comment, sign in
-
Digital Therapeutics: The Future Of Personalized Medicine! In this article, our CEO Ayush Jain, discusses the transformative potential of digital therapeutics (DTx) in the healthcare industry. As chronic diseases become more prevalent, the need for tailored, evidence-based treatment solutions has never been greater. Discover how DTx is reshaping chronic disease management, enhancing patient engagement, and paving the way for a more holistic, patient-centered healthcare future. Read the full article here. 👇 https://lnkd.in/dyuQr2Qx #DigitalHealth #PersonalizedMedicine #ChronicDisease #Innovation #HealthcareTechnology Innovation & Tech Today American Medical Association American Hospital Association Digital Health Insights Becker's Healthcare FDA McKinsey & Company Pravin Uttarwar Manisha Khadge
To view or add a comment, sign in
70 followers